MARC details
000 -LEADER |
fixed length control field |
01999pam a2200301 i 4500 |
001 - CONTROL NUMBER |
control field |
021201506 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
UkOxU |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200127163834.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
200127s2018 enk 001|0|eng|d |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
National bibliography number |
GBB866731 |
Source |
bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
018829532 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781509868063 : (hbk.) |
Terms of availability |
£20.00 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(Uk)018829532 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
StDuBDS |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
StDuBDS |
Modifying agency |
UkOxU |
-- |
IeDuRDS |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
338.7681 |
Edition number |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Carreyrou, John |
9 (RLIN) |
135331 |
245 10 - TITLE STATEMENT |
Title |
Bad blood : |
Remainder of title |
secrets and lies in a Silicon Valley startup / |
Statement of responsibility, etc. |
John Carreyrou. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
London : |
Name of producer, publisher, distributor, manufacturer |
Picador, |
Date of production, publication, distribution, manufacture, or copyright notice |
2018. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
x, 339 p. ; |
Dimensions |
24 cm |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.<br/><br/>Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.<br/> |
600 10 - SUBJECT ADDED ENTRY--PERSONAL NAME |
Personal name |
Holmes, Elizabeth, |
9 (RLIN) |
135332 |
Dates associated with a name |
1984- |
610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Theranos (Firm) |
9 (RLIN) |
135333 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Hematologic equipment industry |
Geographic subdivision |
United States. |
9 (RLIN) |
135335 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Fraud |
Geographic subdivision |
United States. |
9 (RLIN) |
97429 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Information technology |
9 (RLIN) |
51040 |
General subdivision |
Economic aspects. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Loanable Book |